Skip to main content

Animations

MJFF Publications

2281 - 2290 of 8823 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2019
  • 2019
  • 2020
  • 2019
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/58956
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Microgravity: A Tool for Protein Drug Development
    Journal Name: International Journal of Pharmaceutical Sciences Review and Research
    Publisher: Global Research Online
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.47583/ijpsrr.2020.v64i02.014
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Choosing a Parkinson Disease Treatment
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2020.1224
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Freezing of Gait and Its Levodopa Paradox
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4006
    Citation Count: 61
  • Summary Details
    OPEN
    Title: Seven-Year Experience From the National Institute of Neurological Disorders and Stroke–Supported Network for Excellence in Neuroscience Clinical Trials
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.0367
    Citation Count: 9
  • Summary Details
    OPEN
    Title: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Factors Associated with Health‐Related Quality of Life in Late‐Stage Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13186
    Citation Count: 33
  • Summary Details
    OPEN
    Title: β‐Blocker–Induced Tremor
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13176
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Fracture Risk Assessment in Atypical Parkinsonian Syndromes
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13146
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.